Interaction between Spike Protein of SARS-CoV-2 and Human Virus Receptor ACE2 Using Two-Color Fluorescence Cross-Correlation Spectroscopy

Infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the cause of coronavirus disease 2019 (COVID-19), is initiated by the interaction between a receptor protein, angiotensin-converting enzyme type 2 (ACE2) on the cell surface, and the viral spike (S) protein. This interactio...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ai Fujimoto, Yidan Lyu, Masataka Kinjo, Akira Kitamura
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
T
Acceso en línea:https://doaj.org/article/1cd14c87d6584ffb9e635ccb84af3d98
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1cd14c87d6584ffb9e635ccb84af3d98
record_format dspace
spelling oai:doaj.org-article:1cd14c87d6584ffb9e635ccb84af3d982021-11-25T16:35:40ZInteraction between Spike Protein of SARS-CoV-2 and Human Virus Receptor ACE2 Using Two-Color Fluorescence Cross-Correlation Spectroscopy10.3390/app1122106972076-3417https://doaj.org/article/1cd14c87d6584ffb9e635ccb84af3d982021-11-01T00:00:00Zhttps://www.mdpi.com/2076-3417/11/22/10697https://doaj.org/toc/2076-3417Infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the cause of coronavirus disease 2019 (COVID-19), is initiated by the interaction between a receptor protein, angiotensin-converting enzyme type 2 (ACE2) on the cell surface, and the viral spike (S) protein. This interaction is similar to the mechanism in SARS-CoV, a close relative of SARS-CoV-2, which was identified in 2003. Drugs and antibodies that inhibit the interaction between ACE2 and S proteins could be key therapeutic methods for preventing viral infection and replication in COVID-19. Here, we demonstrate the interaction between human ACE2 and a fragment of the S protein (S1 subunit) derived from SARS-CoV-2 and SARS-CoV using two-color fluorescence cross-correlation spectroscopy (FCCS), which can detect the interaction of fluorescently labeled proteins. The S1 subunit of SARS-CoV-2 interacted in solution with soluble ACE2, which lacks a transmembrane region, more strongly than that of SARS-CoV. Furthermore, one-to-one stoichiometry of the two proteins during the interaction was indicated. Thus, we propose that this FCCS-based interaction detection system can be used to analyze the interaction strengths of various mutants of the S1 subunit that have evolved during the worldwide pandemic, and also offers the opportunity to screen and evaluate the performance of drugs and antibodies that inhibit the interaction.Ai FujimotoYidan LyuMasataka KinjoAkira KitamuraMDPI AGarticleCOVID-19spike proteinACE2fluorescence cross-correlation spectroscopycoronavirusTechnologyTEngineering (General). Civil engineering (General)TA1-2040Biology (General)QH301-705.5PhysicsQC1-999ChemistryQD1-999ENApplied Sciences, Vol 11, Iss 10697, p 10697 (2021)
institution DOAJ
collection DOAJ
language EN
topic COVID-19
spike protein
ACE2
fluorescence cross-correlation spectroscopy
coronavirus
Technology
T
Engineering (General). Civil engineering (General)
TA1-2040
Biology (General)
QH301-705.5
Physics
QC1-999
Chemistry
QD1-999
spellingShingle COVID-19
spike protein
ACE2
fluorescence cross-correlation spectroscopy
coronavirus
Technology
T
Engineering (General). Civil engineering (General)
TA1-2040
Biology (General)
QH301-705.5
Physics
QC1-999
Chemistry
QD1-999
Ai Fujimoto
Yidan Lyu
Masataka Kinjo
Akira Kitamura
Interaction between Spike Protein of SARS-CoV-2 and Human Virus Receptor ACE2 Using Two-Color Fluorescence Cross-Correlation Spectroscopy
description Infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the cause of coronavirus disease 2019 (COVID-19), is initiated by the interaction between a receptor protein, angiotensin-converting enzyme type 2 (ACE2) on the cell surface, and the viral spike (S) protein. This interaction is similar to the mechanism in SARS-CoV, a close relative of SARS-CoV-2, which was identified in 2003. Drugs and antibodies that inhibit the interaction between ACE2 and S proteins could be key therapeutic methods for preventing viral infection and replication in COVID-19. Here, we demonstrate the interaction between human ACE2 and a fragment of the S protein (S1 subunit) derived from SARS-CoV-2 and SARS-CoV using two-color fluorescence cross-correlation spectroscopy (FCCS), which can detect the interaction of fluorescently labeled proteins. The S1 subunit of SARS-CoV-2 interacted in solution with soluble ACE2, which lacks a transmembrane region, more strongly than that of SARS-CoV. Furthermore, one-to-one stoichiometry of the two proteins during the interaction was indicated. Thus, we propose that this FCCS-based interaction detection system can be used to analyze the interaction strengths of various mutants of the S1 subunit that have evolved during the worldwide pandemic, and also offers the opportunity to screen and evaluate the performance of drugs and antibodies that inhibit the interaction.
format article
author Ai Fujimoto
Yidan Lyu
Masataka Kinjo
Akira Kitamura
author_facet Ai Fujimoto
Yidan Lyu
Masataka Kinjo
Akira Kitamura
author_sort Ai Fujimoto
title Interaction between Spike Protein of SARS-CoV-2 and Human Virus Receptor ACE2 Using Two-Color Fluorescence Cross-Correlation Spectroscopy
title_short Interaction between Spike Protein of SARS-CoV-2 and Human Virus Receptor ACE2 Using Two-Color Fluorescence Cross-Correlation Spectroscopy
title_full Interaction between Spike Protein of SARS-CoV-2 and Human Virus Receptor ACE2 Using Two-Color Fluorescence Cross-Correlation Spectroscopy
title_fullStr Interaction between Spike Protein of SARS-CoV-2 and Human Virus Receptor ACE2 Using Two-Color Fluorescence Cross-Correlation Spectroscopy
title_full_unstemmed Interaction between Spike Protein of SARS-CoV-2 and Human Virus Receptor ACE2 Using Two-Color Fluorescence Cross-Correlation Spectroscopy
title_sort interaction between spike protein of sars-cov-2 and human virus receptor ace2 using two-color fluorescence cross-correlation spectroscopy
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/1cd14c87d6584ffb9e635ccb84af3d98
work_keys_str_mv AT aifujimoto interactionbetweenspikeproteinofsarscov2andhumanvirusreceptorace2usingtwocolorfluorescencecrosscorrelationspectroscopy
AT yidanlyu interactionbetweenspikeproteinofsarscov2andhumanvirusreceptorace2usingtwocolorfluorescencecrosscorrelationspectroscopy
AT masatakakinjo interactionbetweenspikeproteinofsarscov2andhumanvirusreceptorace2usingtwocolorfluorescencecrosscorrelationspectroscopy
AT akirakitamura interactionbetweenspikeproteinofsarscov2andhumanvirusreceptorace2usingtwocolorfluorescencecrosscorrelationspectroscopy
_version_ 1718413065180938240